|
PHAX expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.30190000002806E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.39530000465538E-08 |
| Normal-vs-Stage2 |
1.010270E-02 |
| Normal-vs-Stage3 |
5.600200E-01 |
| Normal-vs-Stage4 |
1.216620E-01 |
| Stage1-vs-Stage2 |
6.166200E-01 |
| Stage1-vs-Stage3 |
3.429800E-02 |
| Stage1-vs-Stage4 |
6.370200E-01 |
| Stage2-vs-Stage3 |
2.169800E-01 |
| Stage2-vs-Stage4 |
9.081400E-01 |
| Stage3-vs-Stage4 |
4.393000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.49550000050347E-07 |
| Normal-vs-AfricanAmerican |
2.599600E-03 |
| Normal-vs-Asian |
9.389200E-01 |
| Caucasian-vs-AfricanAmerican |
5.836400E-01 |
| Caucasian-vs-Asian |
2.632800E-01 |
| AfricanAmerican-vs-Asian |
3.772000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.95479982095992E-10 |
| Normal-vs-Female |
3.963800E-01 |
| Male-vs-Female |
1.584700E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.124900E-03 |
| Normal-vs-Extreme_Weight |
4.56880000498927E-08 |
| Normal-vs-Obese |
1.321610E-03 |
| Normal-vs-Extreme_Obese |
5.290000E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.387800E-01 |
| Normal_Weight-vs-Obese |
5.835400E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.908000E-01 |
| Extreme_Weight-vs-Obese |
1.131760E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.804400E-01 |
| Obese-vs-Extreme_Obese |
5.180400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.918400E-02 |
| Normal-vs-Age(41-60Yrs) |
2.059600E-03 |
| Normal-vs-Age(61-80Yrs) |
2.25030000189363E-08 |
| Normal-vs-Age(81-100Yrs) |
2.551600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.277400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.268200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.957600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.483500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.369200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.577200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.29839999862824E-08 |
| Normal-VS-Type2 PRCC |
5.461700E-02 |
| Normal-VS-KIRP CIMP |
5.7686999999973E-05 |
| Normal-VS-Unclassified PRCC |
5.128500E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.843800E-02 |
| Type1 PRCC-VS-KIRP CIMP |
7.035000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.681400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.863900E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
6.230600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.702800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.06740000000028E-05 |
| Normal-vs-N1 |
8.979600E-01 |
| Normal-vs-N2 |
2.21239999999012E-05 |
| N0-vs-N1 |
9.864800E-03 |
| N0-vs-N2 |
4.121600E-01 |
| N1-vs-N2 |
7.438200E-02 |
|
|
